Role of abnormal integrin-cytoskeletal interactions in impaired β1 integrin function in chronic myelogenous leukemia hematopoietic progenitors

Experimental Hematology

Volumn 27, Issue 9, 1999, Pages 1384-1396

  Bhatia, Ravi ^a   Munthe, Heidi A ^a   Verfaillie, Catherine M ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b Division of Hematology   (United States)

Author keywords

BCR ABL; Chronic myelogenous leukemia; Cytoskeleton; Hematopoietic progenitors; Integrin

Indexed keywords

ACTIN; ALPHA INTERFERON; ANTIBODY; CD34 ANTIGEN; F ACTIN; HYDROXYUREA; INTEGRIN; RECEPTOR; RETINOIC ACID;

ACTIN POLYMERIZATION; ARTICLE; CELL ADHESION; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS LINKING; CYTOSKELETON; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL;

ACTINS; ANTIGENS, CD29; CELL ADHESION; CELL DIVISION; CELL MEMBRANE; CELLS, CULTURED; CYTOCHALASIN D; CYTOSKELETON; FUSION PROTEINS, BCR-ABL; HEMATOPOIETIC STEM CELLS; HUMANS; INTERFERON ALFA-2B; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; RECEPTOR AGGREGATION; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR STEM CELLS;

EID: 0032870298     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00084-3     Document Type: Article

References (54)

1. Verfaillie C.M., McCarthy J.B., McGlave P.B. Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their adhesion to fibronectin. J Exp Med. 174:1991;693.
2. hi stem cells to bone marrow stroma. J Clin Invest. 90:1992;358.
3. Williams D.A., Rios M., Stephen C.S., Patel V.P. Fibronectin and VLA-4 in hematopoietic stem cell-microenvironment interactions. Nature. 352:1991;438.
4. Miyake K., Weissman I.L., Greenberger J.S., Kincade P.W. Evidence for a role of the integrin VLA-4 in lympho-hemopoeisis. J Exp Med. 173:1991;599.
5. Hurley R.W., McCarthy J.B., Verfaillie C.M. Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation. J Clin Invest. 96:1995;511.
6. Gordon M.Y., Dowding C.R., Riley G.P., Goldman J.M., Greaves M.F. Altered adhesive interactions with marrow stroma of hematopoietic progenitor cells in chronic myelogenous leukaemia. Nature. 328:1984;342.
7. Eaves A.C., Cashman J.D., Gaboury L.A., Kalousek D.K., Eaves C.J. Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells. Proc Natl Acad Sci U S A. 83:1986;5306.
8. Verfaillie C.M., McCarthy J.B., McGlave P.B. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV J Clin Invest. 90:1992;1232.
9. Bhatia R., McCarthy J.B., Verfaillie C.M. Interferon-alpha restores normal beta 1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia. Blood. 87:1996;3883.
10. Hynes R.O. Integrins. versatility, modulation signaling in cell adhesion Cell. 69:1992;11.
11. Clark E.A., Brugge J.S. Integrins and signal transduction pathways. the road taken Science. 268:1995;233.
12. Miyamoto S., Akiyama S.K., Yamada K.M. Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science. 267:1995;883.
13. Burridge K., Fath K., Kelly T., Nuckolls G., Turner C. Focal adhesions. transmembrane junctions between the extracellular matrix and the cytoskeleton Annu Rev Cell Biol. 4:1988;487.
14. Schwartz M.A., Schaller M.D., Ginsberg M.H. Integrins. emerging paradigms of signal transduction Annu Rev Cell Dev Biol. 11:1995;549.
15. Salgia R., Avraham S., Pisick E., Li J.-L., Raja S., Greenfield E., Sattler M., Avraham H., Griffin J. The related adhesion focal tyrsoine kinase forms a complex with paxillin in hematopoietic cells. J Biol Chem. 271:1996;31222.
16. Guinebault C., Payrastre B., Racaud-Sultan C., Mazarguil H., Breton M., Mauco G., Plantavid M., Chap H. Integrin-dependent translocation of phosphoinositide 3-kinase to the cytoskeleton of thrombin-activated platelets involves specific interactions of p85α with actin filaments and focal adhesion kinase. J Cell Biol. 129:1995;831.
17. Rowley J.D. A new consistent chromosome abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature. 243:1973;209.
18. DeKlein A., Van Kessel A.G., Grosveld G., Bartram C.R., Hagemeijer A., Bostooma D., Spurr N.K., Heisterkamp N., Groffen J., Stephenson J.R. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukemia. Nature. 300:1982;765.
19. Daley G.Q., Baltimore D. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic leukemia-specific P210 bcr/abl protein. Proc Natl Acad Sci U S A. 85:1988;9312.
20. Daley G.Q., Van Etten R.A., Baltimore D. Induction of chronic myelogenous leukemia in mice by the p210 bcr/abl gene of the Philadelphia chromosome. Science. 247:1990;824.
21. McWhirter J.R., Wang J.Y.J. Activation of tyrosine kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins. Mol Cell Biol. 11:1991;1553.
22. Van Etten R., Jackson P., Baltimore D., Sanders M., Matsudaira P., Janmey P. The COOH terminus of c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity. J Cell Biol. 1994;124:1994;325.
23. McWhirter J.R., Wang J.Y.J. An actin-binding function contributes to transformation by the BCR-ABL oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J. 12:1993;1533.
24. Oda T., Heaney C., Hagopian J.R., Okuda K., Griffin J.D., Druker B.J. Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia. J Biol Chem. 269:1994;22925.
25. Gotoh A., Miyazawa K., Ohyashiki K., Tauchi T., Boswell H.S., Broxmeyer H.E., Toyama K. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein. Exp Hematol. 23:1995;1153.
26. BCR/ABL. Oncogene. 11:1995;1149.
27. BCR/ABL. J Biol Chem. 270:1995;5039.
28. Bhatia R., Verfaillie C.M. Inhibition of BCR-ABL expression with antisense oligonucleotides restores β1 integrin mediated adhesion and proliferation inhibition in chronic myelogenous leukemia hematopoietic progenitors. Blood. 91:1998;3414.
29. Bhatia R., Munthe H.M., Verfaillie C.M. Tyrphosin AG 957, a tyrosine kinase inhibitor with anti-BCR/ABL tyrosine kinase activity restores β1 integrin mediated adhesion and inhibitory signaling in chronic myelogenous leukemia hematopoietic progenitors. Leukemia. 12:1998;1708.
30. Hurley R.W., McCarthy J.B., Wayner E.A., Verfaillie C.M. Monoclonal antibody cross-linking of the alpha 4 or beta 1 integrin inhibits committed clonogenic hematopoietic progenitor proliferation. Exp Hematol. 25:1997;321.
31. Sirard C., Laneuville P., Dick J.E. Expression of bcr-abl abrogates factor-dependent growth of human hematopoietic M07E cells by an autocrine mechanism. Blood. 83:1994;1575.
32. Yauch R.L., Felsenfeld D.P., Kraeft S.-K., Chen L.B., Sheetz M.P., Hemler M.E. Mutational evidence for control of cell adhesion through integrin diffusion/clustering, independent of ligand binding. J Exp Med. 186:1997;1347.
33. Lofgren R., Ng-Sikorski J., Sjolanfer A., Andersson T. β2 integrin engagement triggers actin polymerization and phosphatidylinositol triphosphate formation in non-adherent human neutrophils. J Cell Biol. 123:1993;1597.
34. Bhatia R., Wayner E.A., McGlave P.B., Verfaillie C.M. Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function. J Clin Invest. 94:1994;384.
35. Verfaillie C.M., Catanzarro P.M., Li W.N. Macrophage inflammatory protein 1 alpha, interleukin 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro. J Exp Med. 179:1994;643.
36. Kucik D.F., Dustin M.L., Miller J.M., Brown E.J. Adhesion-activating phorbol ester increases the mobility of leukocyte integrin LFA-1 in cultured lymphocytes. J Clin Invest. 97:1996;2139.
37. Faull R.J., Kovach N.L., Harlan J.M., Ginsberg M.H. Stimulation of integrin-mediated adhesion of T lymphocytes and monocytes. two mechanisms with divergent biological consequences J Exp Med. 179:1994;1307.
38. O'Toole T., Katagiri Y., Faull R.J., Peter K., Tamura R., Quaranta V., Loftus J.C., Shattil S.J., Ginsberg M.H. Integrin cytoplasmic domains mediate inside-out signal transduction. J Cell Biol. 124:1994;1047.
39. Salgia R., Li J.-L., Ewaniuk D.S., Pear W., Pisick E., Burky S.A., Ernst T., Sattler M., Chen L.B., Griffin J.D. BCR/ABL induces multiple abnormalities of cytoskeletal function. J Clin Invest. 100:1997;46.
40. McWhirter J.R., Wang J.Y.J. Effect of Bcr sequences on the cellular function of the Bcr-Abl oncoprotein. Oncogene. 15:1997;1625.
41. Dahl S.C., Geib R.W., Fox M.T., Edidin M., Branton D. Rapid capping in α-spectrin-deficient MEL cells from mice afflicted with hereditary hemolytic anemia. J Cell Biol. 125:1994;1057.
42. 2+-dependent process. J Cell Biol. 140:1998;699.
43. Chuang T.-H., Xu X., Kaartinen V., Heisterkamp N., Groffen J., Bokoch G. Abr and Bcr are multifunctional regulators of the Rho-GTP-binding family. Proc Natl Acad Sci USA. 92:1995;10282.
44. Bhat A., Kolibaba K., Oda T., Ohno-Jones S., Heaney C., Druker B.J. Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed myeloid cells. J Biol Chem. 272:1997;16170.
45. Skorski T., Kanakaraj P., Nieborowska-Skorska M., Ratajczak M.Z., Shau-Ching W., Zon G., Gewirtz A.M., Perussia B., Calabretta B. Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells. Blood. 86:1995;726.
46. BCR/ABL to the phosphoinositol-3′ kinase pathway. Oncogene. 12:1996;839.
47. Keely P.J., Westwick J.K., Whitehead I.P., Channing C.J., Parise L.V. Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature. 390:1997;632.
48. Salgia R., Uemera N., Okuda K., Li J.-L., Pisick E., Sattler M., de Jong R., Druker B., Heisterkamp N., Chen L., Groffen J., Griffin J. CRKL links p210BCR/ABL with paxillin in chronic myelogenous leukemia cells. J Biol Chem. 270:1995;29145.
49. Salgia R., Pisick E., Sattler M., Li J.-L., Uemura N., Wong W.-K., Burky S.A., Hirai H., Chen L.B., Griffin J.D. p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene. JBiol Chem. 271:1996;25198.
50. Manie S.N., Beck A.R.P., Astier A., Law S.F., Canty T., Hirai H., Druker B.J., Avraham H., Haghayeghi N., Sattler M., Salgia R., Griffin J.D.et al. Involvement of p130cas and p105HEF1, a novel Cas-like docking protein, in a cytoskeleton-dependent signaling pathway initiated by ligation of integrin or antigen receptor on human B cells. J Biol Chem. 272:1997;4230.
51. de Jong R., van Wijk A., Haataja L., Heisterkamp N., Groffen J. BCR/ABL-induced leukemogenesis causes phosphorylation of Hef1 and its association with Crkl. J Biol Chem. 272:1997;32649.
52. Chia C.P., Khrebtukova I., McCluskey J., Wade W.F. MHC class II molecules that lack cytoplasmic domains are associated with the cytoskeleton. J Immunol. 153:1994;3398.
53. Bourguignon L.Y., Iida N., Welsh C.F., Zhu D., Krongrad A., Pasquale D. Involvement of CD44 and its variant isoforms in membrane-cytoskeleton interaction, cell adhesion and tumor metastasis. J Neurooncol. 26:1995;201.
54. Zhao R.C.H., Tarone G., Verfaillie C.M. Presence of the adhesion inhibitory β1b integrin isoform on CML but not normal progenitors is at least in part responsible for the decreased CML progenitor adhesion. Blood. 90:1997;393A.